» Articles » PMID: 38891833

Development of a Sampling and Storage Protocol of Extracellular Vesicles (EVs)-Establishment of the First EV Biobank for Polytraumatized Patients

Abstract

In the last few years, several studies have emphasized the existence of injury-specific EV "barcodes" that could have significant importance for the precise diagnosis of different organ injuries in polytrauma patients. To expand the research potential of the NTF (network trauma research) biobank of polytraumatized patients, the NTF research group decided to further establish a biobank for EVs. However, until now, the protocols for the isolation, characterization, and storage of EVs for biobank purposes have not been conceptualized. Plasma and serum samples from healthy volunteers (n = 10) were used. Three EV isolation methods of high relevance for the work with patients' samples (ultracentrifugation, size exclusion chromatography, and immune magnetic bead-based isolation) were compared. EVs were quantified using nanoparticle tracking analysis, EV proteins, and miRNAs. The effects of different isolation solutions; the long storage of samples (up to 3 years); and the sensibility of EVs to serial freezing-thawing cycles and different storage conditions (RT, 4/-20/-80 °C, dry ice) were evaluated. The SEC isolation method was considered the most suitable for EV biobanking. We did not find any difference in the quantity of EVs between serum and plasma-EVs. The importance of particle-free PBS as an isolation solution was confirmed. Plasma that has been frozen for a long time can also be used as a source of EVs. Serial freezing-thawing cycles were found to affect the mean size of EVs but not their amount. The storage of EV samples for 5 days on dry ice significantly reduced the EV protein concentration.

Citing Articles

Extracellular vesicles epitopes as potential biomarker candidates in patients with traumatic spinal cord injury.

Horauf J, Schindler C, Schaible I, Wang M, Weber B, El Saman A Front Immunol. 2024; 15:1478786.

PMID: 39703513 PMC: 11656158. DOI: 10.3389/fimmu.2024.1478786.

References
1.
Roura S, Bayes-Genis A . Toward Standardization of Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Therapeutic Use: A Call for Action. Proteomics. 2018; 19(1-2):e1800397. DOI: 10.1002/pmic.201800397. View

2.
Huang S, Ji X, Jackson K, Lubman D, Ard M, Bruce T . Rapid separation of blood plasma exosomes from low-density lipoproteins via a hydrophobic interaction chromatography method on a polyester capillary-channeled polymer fiber phase. Anal Chim Acta. 2021; 1167:338578. PMC: 8164660. DOI: 10.1016/j.aca.2021.338578. View

3.
Coumans F, Brisson A, Buzas E, Dignat-George F, Drees E, El-Andaloussi S . Methodological Guidelines to Study Extracellular Vesicles. Circ Res. 2017; 120(10):1632-1648. DOI: 10.1161/CIRCRESAHA.117.309417. View

4.
Weber B, Sturm R, Henrich D, Marzi I, Leppik L . CD44+ and CD31+ extracellular vesicles (EVs) are significantly reduced in polytraumatized patients with hemorrhagic shock - evaluation of their diagnostic and prognostic potential. Front Immunol. 2023; 14:1196241. PMC: 10471799. DOI: 10.3389/fimmu.2023.1196241. View

5.
Weber B, Sturm R, Henrich D, Lupu L, Rottluff K, Marzi I . Diagnostic and Prognostic Potential of Exosomal Cytokines IL-6 and IL-10 in Polytrauma Patients. Int J Mol Sci. 2023; 24(14). PMC: 10380769. DOI: 10.3390/ijms241411830. View